InspireMD (NSPR) Scheduled to Post Quarterly Earnings on Wednesday

InspireMD (NYSEAMERICAN:NSPR) will be posting its quarterly earnings results on Wednesday, March 28th.

InspireMD (NYSEAMERICAN:NSPR) last announced its earnings results on Wednesday, February 14th. The medical equipment provider reported ($7.38) EPS for the quarter. InspireMD had a negative net margin of 179.74% and a negative return on equity of 720.33%. The business had revenue of $0.83 million for the quarter.

How to Become a New Pot Stock Millionaire

Shares of InspireMD (NYSEAMERICAN:NSPR) opened at $2.17 on Monday. InspireMD has a twelve month low of $0.70 and a twelve month high of $36.75. The company has a market cap of $7.11, a P/E ratio of -0.12 and a beta of 2.61.

WARNING: This piece of content was reported by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another site, it was illegally copied and reposted in violation of US and international copyright & trademark law. The legal version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3300649/inspiremd-nspr-scheduled-to-post-quarterly-earnings-on-wednesday.html.

InspireMD Company Profile

InspireMD, Inc is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures.

Earnings History for InspireMD (NYSEAMERICAN:NSPR)

Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Ninetowns Internet Technlgy Grp  Receiving Somewhat Favorable Media Coverage, Study Finds
Ninetowns Internet Technlgy Grp Receiving Somewhat Favorable Media Coverage, Study Finds
EA Coin Trading Up 27% This Week
EA Coin Trading Up 27% This Week
Financial Survey: Five Below  & Dollar General
Financial Survey: Five Below & Dollar General
Critical Comparison: Alphabet  vs. Its Rivals
Critical Comparison: Alphabet vs. Its Rivals
Financial Contrast: Hilton Grand Vacations  versus Civeo
Financial Contrast: Hilton Grand Vacations versus Civeo
Zacks: Fennec Pharmaceuticals Inc  Given $17.50 Average Price Target by Analysts
Zacks: Fennec Pharmaceuticals Inc Given $17.50 Average Price Target by Analysts


© 2006-2018 Ticker Report. Google+.